Viz RV/LV vs Us2.v1
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Viz RV/LV is specifically designed for rapid pulmonary embolism risk stratification by automating RV/LV ratio measurements from CTPA scans. In contrast, Us2.v1 offers comprehensive, fully automated analysis of echocardiography data for a broader range of cardiac measurements and disease detection. While both leverage AI for cardiac diagnostics, their distinct imaging modalities and primary clinical applications make them suitable for different workflows and diagnostic questions.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Viz RV/LV is designed to analyze volumetric CTPA (Computed Tomography Pulmonary Angiography) scans to measure the right ventricle to left ventricle (RV/LV) ratio. In contrast, Us2.v1 provides fully automated AI software for the analysis of echocardiography images.
Viz RV/LV focuses on automating RV/LV ratio measurements from CTPA scans for rapid pulmonary embolism (PE) risk stratification and detection of potential right ventricle dilation. Us2.v1 offers comprehensive echocardiography analysis, including automated measurements and detection of diseases such as cardiac amyloidosis and pulmonary hypertension, covering a vast majority of standard adult transthoracic echocardiography measurements.
Viz RV/LV is intended to support specialties such as Emergency Medicine, Pulmonology, and Radiology. Us2.v1 is primarily designed to support Cardiology.
Viz RV/LV is a seamless component of the Viz PE Solution, providing AI-powered alerts and a HIPAA-compliant communication platform for care coordination among care teams. Us2.v1 generates comprehensive structured reports with measurements and disease detection in seconds, aiming to improve workflow efficiency and diagnostic accuracy for echocardiography, with editable annotations and conclusions.